Ignite Creation Date:
2024-05-06 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03460977
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2018-02-12
Brief Title:
Mevrometostat Treatment of RelapsedRefractory SCLC Castration Resistant Prostate Cancer and Follicular Lymphoma
Sponsor:
Organization:
Pfizer